More on AQST

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (8/11/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Aquestive Therapeutics Inc. (NQ:AQST)
Delayed: 4.22 -0.04 (0.94%)
Prev. Close $4.26  
Open$4.17 
52 Wk High$ 
52 Wk Low$ 
Day High$4.25 
Day Low$4.07 
P/E N/A  
EPS$ 
Volume2,408,051 

Friends, Peers and Foes (?): TLSA (more...)

Mar 6, 2026 11:42 AM Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Aquestive Therapeutics, Inc. (AQST)
Mar 6, 2026 04:38 AM Aquestive Therapeutics (AQST) Reiterated at Market Outperform by Citizens Before FDA Meet
Mar 4, 2026 05:20 PM Form S-8 Aquestive Therapeutics,
Mar 4, 2026 04:22 PM Form 10-K Aquestive Therapeutics, For: Dec 31
Mar 4, 2026 04:11 PM Aquestive Therapeutics Inc. (AQST) Misses Q4 EPS by 13c
Mar 4, 2026 04:11 PM Form 8-K Aquestive Therapeutics, For: Mar 03
Mar 4, 2026 04:01 PM Aquestive Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Feb 26, 2026 08:07 AM Form 8-K Aquestive Therapeutics, For: Feb 26
Feb 25, 2026 07:00 AM Aquestive Therapeutics to Participate in Upcoming March Investor Conferences
Feb 24, 2026 07:00 AM Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET
View All Articles

Entities mentioned with AQST

View All Entities